Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 33.00
-0.73 (-2.16%)
Aug 4, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 4.74 billion as of August 4, 2026.
Market Cap
4.74B
Enterprise Value
4.07B
Revenue
3.61B
Ranking
n/a
PE Ratio
28.01
Stock Price
33.00
ChartMarket Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 4.74B, a decrease of -50.57%. That is a compound annual growth rate of -61.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.74B | -21.05% |
| Dec 31, 2025 | 6.00B | -37.39% |
| Nov 5, 2025 | 9.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.37B |
| Hangzhou Biotest Biotech | 5.32B |
| R&G PharmaStudies | 4.87B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.73B |
| Beijing Konruns Pharmaceutical | 4.70B |
| Shenzhen Weiguang Biological Products | 4.58B |
| ChemPartner PharmaTech | 4.54B |
| Xiangxue Pharmaceutical | 4.46B |